Invesco’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Invesco’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-7,325	Closed	-$998K	–	3769
2016 Q4	$998K	Buy	+7,325	New	+$1.3M	﹤0.01%	2996
2015 Q3	–	Sell	-24	Closed	-$5K	–	4055
2015 Q2	$5K	Buy	+24	New	+$5.88K	﹤0.01%	4234

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco's BLCM Position: Q1 2017 in Review

Invesco sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2017, closing a stake of 7,325 shares — an estimated $998K sold.

Invesco first reported a position in BLCM in Q2 2015 and held it in 2 quarters. The position peaked at $998K in Q4 2016. 96 funds tracked by Wall St. Rank hold BLCM as of Q1 2017.

Invesco reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Invesco sold 7,325 Bellicum Pharmaceuticals, Inc. shares in Q1 2017, an estimated $998K.
Invesco first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2015 and held it in 2 quarters.
Invesco's Bellicum Pharmaceuticals, Inc. position peaked at $998K in Q4 2016.
96 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2017.

Based on Invesco's 13F filing for Q1 2017, filed 15 May 2017.